Medical Journals

Genotype Prevalence and Risk Factors for Severe Clinical Adenovirus Infection, United States 2004-2006.

Authors:
  • Gray Gregory C
  • McCarthy Troy
  • Lebeck Mark G
  • Schnurr David P
  • Russell Kevin L
  • Kajon Adriana E
  • Landry Marie L
  • Leland Diane S
  • Storch Gregory A
  • Ginocchio Christine C
  • Robinson Christine C
  • Demmler Gail J
  • Saubolle Michael A
  • Kehl Sue C
  • Selvarangan Rangaraj
  • Miller Melissa B
  • Chappell James D
  • Zerr Danielle M
  • Kiska Deanna L
  • Halstead Diane C
  • Capuano Ana W
  • Setterquist Sharon F
  • Chorazy Margaret L
  • Dawson Jeffrey D
  • Erdman Dean D

From: Center for Emerging Infectious Diseases, Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA 52242, USA. gregory-gray@uiowa.edu

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

  • Publish Date: Nov 2007
  • ISSN: 1537-6591
  • Volume: 45
  • Issue: 9
  • Pages: 1120-31
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Gray Gregory C, McCarthy Troy, Lebeck Mark G, et al. Genotype Prevalence and Risk Factors for Severe Clinical Adenovirus Infection, United States 2004-2006.. Clin. Infect. Dis. Nov 2007;45:1120-31

Abstract

BACKGROUND: Recently, epidemiological and clinical data have revealed important changes with regard to clinical adenovirus infection, including alterations in antigenic presentation, geographical distribution, and virulence of the virus. METHODS: In an effort to better understand the epidemiology of clinical adenovirus infection in the United States, we adopted a new molecular adenovirus typing technique to study clinical adenovirus isolates collected from 22 medical facilities over a 25-month period during 2004-2006. A hexon gene sequence typing method was used to characterize 2237 clinical adenovirus-positive specimens, comparing their sequences with those of the 51 currently recognized prototype human adenovirus strains. In a blinded comparison, this method performed well and was much faster than the classic serologic typing method. RESULTS: Among civilians, the most prevalent adenovirus types were types 3 (prevalence, 34.6%), 2 (24.3%), 1 (17.7%), and 5 (5.3%). Among military trainees, the most prevalent types were types 4 (prevalence, 92.8%), 3 (2.6%), and 21 (2.4%). CONCLUSIONS: For both populations, we observed a statistically significant increasing trend of adenovirus type 21 detection over time. Among adenovirus isolates recovered from specimens from civilians, 50% were associated with hospitalization, 19.6% with a chronic disease condition, 11% with a bone marrow or solid organ transplantation, 7.4% with intensive care unit stay, and 4.2% with a cancer diagnosis. Multivariable risk factor modeling for adenovirus disease severity found that age <7 years (odds ratio [OR], 3.2; 95% confidence interval [CI], 1.4-7.4), chronic disease (OR, 3.6; 95% CI, 2.6-5.1), recent transplantation (OR, 2.7; 95% CI, 1.3-5.2), and adenovirus type 5 (OR, 2.7; 95% CI, 1.5-4.7) or type 21 infection (OR, 7.6; 95% CI, 2.6-22.3) increased the risk of severe disease.

Mesh Headings (Keywords): Adenoviridae, Adenovirus Infections, Human, Adolescent, Adult, Child, Child, Preschool, Female, Genotype, Humans, Infant, Male, Microbiological Techniques, Middle Aged, Prevalence, Risk Factors, United States


Check for Full Text / PubMed Unique Identifier (PMID): 17918073


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.